Testing effectiveness (Phase 2)Study completedNCT01896583
What this trial is testing
Pilot Study to Assess ASP7147 in Patients With Diarrhea Predominant Irritable Bowel Syndrome (IBS-D)
Who this might be right for
Diarrhea Predominant Irritable Bowel Syndrome
Seldar Pharma, Inc. 64